Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 51

Results For "ether"

1009 News Found

DG, ICMR and Director CSIR-NIScPR release special issues of Vigyan Pragati & Science Reporter magazines
News | April 13, 2023

DG, ICMR and Director CSIR-NIScPR release special issues of Vigyan Pragati & Science Reporter magazines

Science communication brings behavioural changes


India’s Covid success story hailed the world over as a role model in Crisis Management, says Dr. Singh
Policy | April 13, 2023

India’s Covid success story hailed the world over as a role model in Crisis Management, says Dr. Singh

India's strategy against Covid was more effective than any other countries in the world


ProBioGen and ImmunOs Therapeutics join hands to deliver innovative therapy for cancer patients
News | April 13, 2023

ProBioGen and ImmunOs Therapeutics join hands to deliver innovative therapy for cancer patients

ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs' innovative biologic.


CiRA, Kyoto University and Astellas Phase 2 research agreement signed for iPS Cells
News | April 12, 2023

CiRA, Kyoto University and Astellas Phase 2 research agreement signed for iPS Cells

CiRA, Kyoto University and Astellas - Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells


AIIA to host a Working Group of C20 on Integrated Holistic Health
News | April 08, 2023

AIIA to host a Working Group of C20 on Integrated Holistic Health

The C20 is an engagement group of the G20 that focuses on Civil issues and looks to promote sustainable growth and financial stability.


Cognizant, Microsoft collaborate to bring cloud-based solutions to the healthcare market
Digitisation | April 08, 2023

Cognizant, Microsoft collaborate to bring cloud-based solutions to the healthcare market

Microsoft Cloud for Healthcare and Cognizant’s TriZetto healthcare products aim to enhance transparency for consumers and increase interoperability for providers and payers


Lonza and ABL Bio collaborate on development and manufacture of new bispecific antibody product
News | April 06, 2023

Lonza and ABL Bio collaborate on development and manufacture of new bispecific antibody product

Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution


Israeli researchers develop an effective drug to prevent muscle diseases
News | April 05, 2023

Israeli researchers develop an effective drug to prevent muscle diseases

The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.


EIP Pharma and Diffusion Pharmaceuticals inks agreement to create CNS-focused company
News | April 03, 2023

EIP Pharma and Diffusion Pharmaceuticals inks agreement to create CNS-focused company

EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging